Literature DB >> 18362144

Aberrant folding of pathogenic Parkin mutants: aggregation versus degradation.

Julia S Schlehe1, A Kathrin Lutz, Anna Pilsl, Kerstin Lämmermann, Katja Grgur, Iris H Henn, Jörg Tatzelt, Konstanze F Winklhofer.   

Abstract

Loss-of-function mutations in the Parkin gene (PARK2) are responsible for the majority of autosomal recessive Parkinson disease. A growing body of evidence indicates that misfolding and aggregation of Parkin is a major mechanism of Parkin inactivation, accounting for the loss-of-function phenotype of various pathogenic Parkin mutants. Remarkably, wild-type Parkin is also prone to misfolding under certain cellular conditions, suggesting a more general role of Parkin in the pathogenesis of Parkinson disease. We now show that misfolding of Parkin can lead to two phenotypes: the formation of detergent-insoluble, aggregated Parkin, or destabilization of Parkin resulting in an accelerated proteasomal degradation. By combining two pathogenic Parkin mutations, we could demonstrate that destabilization of Parkin is dominant over the formation of detergent-insoluble Parkin aggregates. Furthermore, a comparative analysis with HHARI, an E3 ubiquitin ligase with an RBR domain highly homologous to that of Parkin, revealed that folding of Parkin is specifically dependent on the integrity of the C-terminal domain, but not on the presence of a putative PDZ-binding motif at the extreme C terminus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18362144     DOI: 10.1074/jbc.M707494200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

2.  Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase Parkin.

Authors:  Fabienne C Fiesel; Thomas R Caulfield; Elisabeth L Moussaud-Lamodière; Kotaro Ogaki; Daniel F A R Dourado; Samuel C Flores; Owen A Ross; Wolfdieter Springer
Journal:  Hum Mutat       Date:  2015-06-03       Impact factor: 4.878

Review 3.  Parkin-mediated selective mitochondrial autophagy, mitophagy: Parkin purges damaged organelles from the vital mitochondrial network.

Authors:  Atsushi Tanaka
Journal:  FEBS Lett       Date:  2010-02-25       Impact factor: 4.124

4.  The PINK1/Parkin pathway regulates mitochondrial dynamics and function in mammalian hippocampal and dopaminergic neurons.

Authors:  Wendou Yu; Yaping Sun; Su Guo; Bingwei Lu
Journal:  Hum Mol Genet       Date:  2011-05-25       Impact factor: 6.150

5.  Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system.

Authors:  Jeanne E McKeon; Di Sha; Lian Li; Lih-Shen Chin
Journal:  Cell Mol Life Sci       Date:  2014-11-18       Impact factor: 9.261

Review 6.  Multitasking in the mitochondrion by the ATP-dependent Lon protease.

Authors:  Sundararajan Venkatesh; Jae Lee; Kamalendra Singh; Irene Lee; Carolyn K Suzuki
Journal:  Biochim Biophys Acta       Date:  2011-11-18

7.  Methamphetamine oxidatively damages parkin and decreases the activity of 26S proteasome in vivo.

Authors:  Anna Moszczynska; Bryan K Yamamoto
Journal:  J Neurochem       Date:  2011-01-19       Impact factor: 5.372

Review 8.  Pathologic and therapeutic implications for the cell biology of parkin.

Authors:  Rakshita A Charan; Matthew J LaVoie
Journal:  Mol Cell Neurosci       Date:  2015-02-17       Impact factor: 4.314

9.  Parkin is protective against proteotoxic stress in a transgenic zebrafish model.

Authors:  Mareike E Fett; Anna Pilsl; Dominik Paquet; Frauke van Bebber; Christian Haass; Jörg Tatzelt; Bettina Schmid; Konstanze F Winklhofer
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

10.  Different conformation of thiol protease inhibitor during amyloid formation: inhibition by curcumin and quercetin.

Authors:  Mohd Shahnawaz Khan; Abdulrahman M Al-Senaidy; Medha Priyadarshini; Aaliya Shah; Bilqees Bano
Journal:  J Fluoresc       Date:  2013-01-22       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.